Abstract
The resection of the primary tumor in patients with metastatic prostate cancer is controversially debated. Retrospective clinical studies indicate survival benefits and prevention of secondary, locoregional complications;however, results of ongoing multicenter prospective studies are still lacking. This review highlights the rationale behind the cytoreductive prostatectomy and summarizes current clinical study results.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 0340-2592 |
Sprache: | Deutsch |
Dokumenten ID: | 50115 |
Datum der Veröffentlichung auf Open Access LMU: | 14. Jun. 2018, 09:42 |
Letzte Änderungen: | 04. Nov. 2020, 13:27 |